Patent · US Active

Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors

US9193692B2 · kind B2 · utility

0Cited by

15References

14Claims

0Family size

Assignee

Signal Pharmaceuticals, LLC · US

Inventors

Sophie Perrin-Ninkovic · Carlsbad, US
Roy L. Harris · San Diego, US
John Sapienza · Chula Vista, US
Graziella I. Shevlin · San Diego, US
Patrick Papa · San Diego, US
Branden Lee · Encinitas, US
Garrick Packard · San Diego, US
Jingjing Zhao · San Diego, US
Jennifer Riggs · Irvine, US
Jason Parnes · San Diego, US
Deborah Mortensen · San Diego, US
Jan Elsner · Solana Beach, US

Key dates

Filing date	Oct 31, 2014
Grant date	Nov 24, 2015
Priority date	—
Expiry date	Oct 31, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are Heteroaryl Compounds having the following structure: Furthermore, provided herein are compounds having the following formulas (IV), (V), (VII) and (VIII):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.